Assessing the economic impact of psychiatric disorders: where to begin?

Author： Greenberg P.E.   Leong S.A.   Birnbaum H.G.  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.4, 2001-04, pp. : 641-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessing the economic impact of chronic conditions in postmenopausal women

By Sasser Alicia C   Taylor Maida   Birnbaum Howard G   Schoenfeld Michael J   Oster Emily F   Rousculp Matthew  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1803-1814

Informa Healthcare

Access to resources Recommend Favorite

Assessing the Economic Impact of Adverse Drug Effects

By Rodríguez-Monguió R.  

PharmacoEconomics, Vol. 21, Iss. 9, 2003-01 ,pp. : 623-650

Adis International

Access to resources Recommend Favorite

Radiopharmaceuticals in Neurological and Psychiatric Disorders

By  

Current Clinical Pharmacology, Vol. 3, Iss. 2, 2008-05 ,pp. : 99-107

Bentham Science Publishers

Access to resources Recommend Favorite

Substance Abuse and Psychiatric Disorders in HIV-Positive Patients: Epidemiology and Impact on Antiretroviral Therapy

By Chander Geetanjali  

Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. : 769-789

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: Impact of Early Life Stress on Psychiatric Disorders: Searching New Biomarkers and Innovative Pharmacological Targets)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 11, 2015-02 ,pp. : 1357-1357

Bentham Science Publishers

Access to resources Recommend Favorite